Heart Failure as a Risk Factor for Stroke

논문상세정보
    • 저자 Woohyeun Kim Eung Ju Kim
    • 제어번호 105081106
    • 학술지명 Journal of stroke
    • 권호사항 Vol. 20 No. 1 [ 2018 ]
    • 발행처 대한뇌졸중학회
    • 발행처 URL http://www.stroke.or.kr
    • 자료유형 학술저널
    • 수록면 33-45
    • 언어 English
    • 출판년도 2018
    • 등재정보 KCI등재
    • 소장기관 강원대학교 춘천캠퍼스 도서관 의학분관
    • 판매처
    유사주제 논문( 0)

' Heart Failure as a Risk Factor for Stroke' 의 참고문헌

  • Warfarin and aspirin in patients with heart failure and sinus rhythm
    Homma S [2012]
  • Viewpoint: the prothrombotic state in heart failure: a maladaptive inflammatory response?
    Chong AY [2007]
  • Ventricular thrombi and thromboembolism in dilated cardiomyopathy: a prospective followup study
    Falk RH [1992]
  • Ventricular dysfunction and the risk of stroke after myocardial infarction
    Loh E [1997]
  • Variability of cerebral blood volume and oxygen extraction: stages of cerebral haemodynamic impairment revisited
    Derdeyn CP [2002]
  • Use of angiotensin-converting enzyme inhibitors and variations in cognitive performance among patients with heart failure
    Zuccala G [2005]
  • Updated meta-analysis on antithrombotic therapy in patients with heart failure and sinus rhythm
    Hopper I [2013]
  • Update on the global burden of ischemic and hemorrhagic stroke in 1990-2013: the GBD 2013 study
    Feigin VL [2015]
  • Type of atrial fibrillation and outcomes in patients with heart failure and reduced ejection fraction
    Mogensen UM [2017]
  • Tissue plasminogen activator release in chronic venous hypertension due to heart failure
    Keber I [1992]
  • Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm: an executive summary of a joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis
    Lip GY [2012]
  • The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure
    Cleland JG [2004]
  • The CHADS2 score predicts ischemic stroke in chronic heart failure patients without atrial fibrillation: comparison to other stroke risk scores
    Kondo T [2017]
  • Systolic heart failure: a prothrombotic state
  • Stroke in patients with heart failure and reduced left ventricular ejection fraction
  • Stroke in heart failure: atrial fibrillation revisited?
    Pullicino P [2010]
  • Stroke and mortality in patients with incident heart failure: the Diet, Cancer and Health (DCH) cohort study
    Lip GY [2012]
  • Stroke aetiology and predictors of outcome in patients with heart failure and acute stroke: a 10-year follow-up study
    Vemmos K [2012]
  • Statins improve survival in patients with cardioembolic stroke
    Choi JY [2014]
  • Silent strokes in patients with heart failure
    Siachos T [2005]
  • Silent cerebral infarcts associated with cardiac disease and procedures
    Hassell ME [2013]
  • Silent cerebral infarction in patients with dilated cardiomyopathy: echocardiographic correlates
    Kozdag G [2006]
  • Silent cerebral infarction in chronic heart failure: ischemic and nonischemic dilated cardiomyopathy
    Kozdag G [2008]
  • Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
    Patel MR [2011]
  • Rivaroxaban in patients with a recent acute coronary syndrome
    Mega JL [2012]
  • Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)
  • Risk of thromboembolism in heart failure
  • Risk of stroke in patients with heart failure: a population-based 30-year cohort study
    Adelborg K [2017]
  • Risk of stroke in congestive heart failure with and without atrial fibrillation
    Kang SH [2017]
  • Risk of stroke in chronic heart failure patients without atrial fibrillation: analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) trials
  • Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials
  • Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study
    He J [2001]
  • Relevance of heart failure in prevention, treatment and prognosis of ischemic stroke
    Haeusler KG [2017]
  • Relationship of carbon dioxide tension in arterial blood to pulmonary wedge pressure in heart failure
  • Relationship between hemostatic abnormalities and neuroendocrine activity in heart failure
    Sbarouni E [1994]
  • Rationale and design of a randomized, double-blind, event-driven, multicentre study comparing the efficacy and safety of oral rivaroxaban with placebo for reducing the risk of death, myocardial infarction or stroke in subjects with heart failure and significant coronary artery disease following an exacerbation of heart failure: the COMMANDER HF trial
    Zannad F [2015]
  • Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial
    Massie BM [2009]
  • Pulsatile hemodynamics in patients with exertional dyspnea: potentially of value in the diagnostic evaluation of suspected heart failure with preserved ejection fraction
    Weber T [2013]
  • Procoagulant state in heart failure with preserved left ventricular ejection fraction
    Jug B [2009]
  • Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group
    Shepherd J [1995]
  • Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction
    Zile MR [2011]
  • Prevalence and prognostic significance of wall-motion abnormalities in adults without clinically recognized cardiovascular disease: the Strong Heart Study
    Cicala S [2007]
  • Poor outcome after firstever stroke: predictors for death, dependency, and recurrent stroke within the first year
    Appelros P [2003]
  • Platelet function, thrombin and fibrinolytic activity in patients with heart failure
    Jafri SM [1993]
  • Persistent activation of coagulation mechanism in unstable angina and myocardial infarction
    Merlini PA [1994]
  • Pathophysiological and therapeutic implications in patients with atrial fibrillation and heart failure
  • Overview of the new oral anticoagulants: opportunities and challenges
    Yeh CH [2015]
  • Non-vitamin K antagonist oral anticoagulants and heart failure
    Isnard R [2016]
  • Non-vitamin K antagonist oral anticoagulants (NOACs) in patients with concomitant atrial fibrillation and heart failure: a systemic review and meta-analysis of randomized trials
    Xiong Q [2015]
  • Nationwide frequency and association of heart failure on stroke outcomes in the United States
    Divani AA [2009]
  • Manifestations of coronary disease predisposing to stroke. The Framingham study
    Kannel WB [1983]
  • Left ventricular wall motion abnormalities are associated with stroke recurrence
    Choi JY [2017]
  • Left ventricular thrombosis, wall motion abnormalities, and blood viscosity changes after first transmural anterior myocardial infarction
  • Left ventricular systolic dysfunction, heart failure, and the risk of stroke and systemic embolism in patients with atrial fibrillation: insights from the ARISTOTLE trial
    McMurray JJ [2013]
  • Left ventricular systolic dysfunction and the risk of ischemic stroke in a multiethnic population
    Hays AG [2006]
  • Left ventricular ejection fraction and risk of stroke and cardiac events in heart failure: data from the warfarin versus aspirin in reduced ejection fraction trial
  • Left ventricular apical thrombus and myocardial viability: a dobutamine stress echocardiographic study
    Cusick DA [2000]
  • Ischemic stroke after heart failure: a community-based study
    Witt BJ [2006]
  • Is diastolic dysfunction associated with thrombogenesis? A study of circulating markers of a prothrombotic state in patients with coronary artery disease
    Lip GY [1995]
  • Intracardiac thrombi and systemic embolization
    Meltzer RS [1986]
  • Interleukin-6, tissue factor and von Willebrand factor in acute decompensated heart failure: relationship to treatment and prognosis
    Chin BS [2003]
  • Impaired tissue Doppler diastolic function in patients with coronary artery disease: relationship to endothelial damage/dysfunction and platelet activation
    Lee KW [2005]
  • Hypercoagulability in heart failure
    Jafri SM [1997]
  • Heart failure: preventing disease and death worldwide
  • Heart failure-induced brain injury
    Havakuk O [2017]
  • Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment
    Borlaug BA [2011]
  • Heart failure on admission and the risk of stroke following acute myocardial infarction: the VALIANT registry
    Szummer KE [2005]
  • Heart failure in acute ischemic stroke
    Ois A [2008]
  • Heart failure and the risk of stroke: the Rotterdam Study
    Alberts VP [2010]
  • Heart disease and stroke statistics: 2010 update: a report from the American Heart Association
  • Heart disease and stroke statistics-2016 update: a report from the American heart association
  • Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015
  • Global burden of stroke
    Feigin VL [2017]
  • Female sex is associated with a lower risk of stroke in patients with heart failure
    Melgaard L [2015]
  • Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management
    Massie BM [1997]
  • Etiology of stroke
    Mohr JP [1997]
  • Epidemiology and aetiology of heart failure
    Ziaeian B [2016]
  • Endotoxin and immune activation in chronic heart failure: a prospective cohort study
    Niebauer J [1999]
  • Endothelium-dependent vasodilation is attenuated in patients with heart failure
    Kubo SH [1991]
  • Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials
    Dries DL [1997]
  • Efficacy of antithrombotic therapy in chronic heart failure: the HELAS study
    Cokkinos DV [2006]
  • Efficacy and safety of rivaroxaban in patients with heart failure and nonvalvular atrial fibrillation: insights from ROCKET AF
  • Efficacy and safety of edoxaban compared with warfarin in patients with atrial fibrillation and heart failure: insights from ENGAGE AF-TIMI 48
    Magnani G [2016]
  • Effects of warfarin therapy on plasma fibrinogen, von Willebrand factor, and fibrin D-dimer in left ventricular dysfunction secondary to coronary artery disease with and without aneurysms
    Lip GY [1995]
  • Effects of warfarin on markers of hypercoagulability in patients with heart failure
    Jafri SM [1997]
  • Edoxaban versus warfarin in patients with atrial fibrillation
  • EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot)
    Maggioni AP [2013]
  • Does heart failure confer a hypercoagulable state? Virchow's triad revisited
    Lip GY [1999]
  • Do patients have worse outcomes in heart failure than in cancer? A primary care-based cohort study with 10-year follow-up in Scotland
    Mamas MA [2017]
  • Dabigatran versus warfarin in patients with atrial fibrillation
    Connolly SJ [2009]
  • Dabigatran compared with warfarin in patients with atrial fibrillation and symptomatic heart failure: a subgroup analysis of the RE-LY trial
    Ferreira J [2013]
  • Cognitive profile in persons with systolic and diastolic heart failure
  • Cognitive impairments in chronic heart failure: a case controlled study
    Sauve MJ [2009]
  • Cognitive impairment in heart failure: results from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF) randomized trial
    Huijts M [2013]
  • Cognitive impairment in heart failure: a systematic review of the literature
    Vogels RL [2007]
  • Cognitive impairment in heart failure
    Dardiotis E [2012]
  • Cognitive and brain changes associated with ischaemic heart disease and heart failure
    Almeida OP [2012]
  • Chronic heart failure and ischemic stroke
    Haeusler KG [2011]
  • Changing epidemiological features of cardiac failure
    Kannel WB [1994]
  • Changes in cerebral blood flow in patients with severe congestive cardiac failure before and after captopril treatment
  • Cerebrovascular reactivity is impaired in patients with cardiac failure
  • Cardioembolic stroke: an update
    Ferro JM [2003]
  • CMR-verified diffuse myocardial fibrosis is associated with diastolic dysfunction in HFpEF
    Su MY [2014]
  • Brain magnetic resonance imaging and neuropsychologic evaluation of patients with idiopathic dilated cardiomyopathy
    Schmidt R [1991]
  • Brain magnetic resonance imaging abnormalities in patients with heart failure
    Vogels RL [2007]
  • Blood pressure and stroke in heart failure in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study
  • Atrial fibrillation in heart failure: stroke risk stratification and anticoagulation
    Abraham JM [2014]
  • Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction
  • Atrial fibrillation as an independent risk factor for stroke: the Framingham Study
    Wolf PA [1991]
  • Atrial fibrillation and heart failure: treatment considerations for a dual epidemic
    Anter E [2009]
  • Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: a systematic review and meta-analysis of death and adverse outcomes
    Kotecha D [2016]
  • Assessment of the CHA2DS2-VASc score in predicting ischemic stroke, thromboembolism, and death in patients with heart failure with and without atrial fibrillation
    Melgaard L [2015]
  • Apixaban versus warfarin in patients with atrial fibrillation
    Granger CB [2011]
  • American Heart Association Prevention Conference. IV. Prevention and rehabilitation of stroke. Risk factors
    Sacco RL [1997]
  • Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm: effects of angiotensin-converting enzyme inhibitor and beta-blocker therapy
    Gibbs CR [2001]
  • A multicentre cohort study of acute heart failure syndromes in Korea : rationale, design, and interim observations of the Korean Acute Heart Failure(KorAHF)registry
    Lee SE [2014]
  • 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
    Kirchhof P [2016]
  • 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure : The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology(ESC)Developed with the special contribution of the Heart Failure Association(HFA)of the ESC
  • 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the Heart Rhythm Society
    January CT [2014]